Testicular Cancer Incidence and Mortality by Year, White Individuals, New York State, 1976-2020
Source: New York State Cancer Registry
Year of Diagnosis/Death | Incidence | Mortality | ||||
---|---|---|---|---|---|---|
Cases | Rate per 100,000 Males | 95% CI | Deaths | Rate per 100,000 Males | 95% CI | |
1976 | 249 | 3.4 | 2.9-3.8 | 48 | 0.6 | 0.4-0.8 |
1977 | 242 | 3.3 | 2.9-3.8 | 44 | 0.6 | 0.4-0.8 |
1978 | 263 | 3.7 | 3.3-4.2 | 49 | 0.7 | 0.5-0.9 |
1979 | 303 | 4.3 | 3.8-4.8 | 47 | 0.7 | 0.5-0.9 |
1980 | 324 | 4.5 | 4.0-5.0 | 44 | 0.6 | 0.4-0.8 |
1981 | 317 | 4.3 | 3.8-4.8 | 32 | 0.4 | 0.3-0.6 |
1982 | 321 | 4.4 | 3.9-4.9 | 32 | 0.5 | 0.3-0.7 |
1983 | 339 | 4.6 | 4.1-5.1 | 30 | 0.4 | 0.3-0.6 |
1984 | 381 | 5.2 | 4.7-5.8 | 27 | 0.4 | 0.3-0.6 |
1985 | 353 | 4.8 | 4.3-5.3 | 34 | 0.5 | 0.3-0.7 |
1986 | 356 | 4.7 | 4.2-5.2 | 34 | 0.5 | 0.3-0.7 |
1987 | 382 | 5.1 | 4.6-5.6 | 27 | 0.4 | 0.2-0.5 |
1988 | 351 | 4.6 | 4.2-5.2 | 23 | 0.3 | 0.2-0.5 |
1989 | 363 | 4.8 | 4.3-5.4 | 31 | 0.4 | 0.3-0.6 |
1990 | 408 | 5.4 | 4.9-6.0 | 24 | 0.3 | 0.2-0.5 |
1991 | 389 | 5.2 | 4.7-5.7 | 22 | 0.3 | 0.2-0.4 |
1992 | 400 | 5.4 | 4.9-6.0 | 28 | 0.4 | 0.3-0.6 |
1993 | 421 | 5.7 | 5.1-6.3 | 32 | 0.5 | 0.3-0.7 |
1994 | 412 | 5.6 | 5.1-6.2 | 21 | 0.3 | 0.2-0.5 |
1995 | 415 | 5.7 | 5.2-6.3 | 22 | 0.3 | 0.2-0.5 |
1996 | 410 | 5.6 | 5.1-6.2 | 26 | 0.4 | 0.2-0.5 |
1997 | 427 | 5.9 | 5.4-6.5 | 12 | 0.2 | 0.1-0.3 |
1998 | 430 | 6.0 | 5.5-6.6 | 25 | 0.3 | 0.2-0.5 |
1999 | 470 | 6.6 | 6.0-7.2 | 17 | 0.2 | 0.1-0.4 |
2000 | 422 | 5.9 | 5.4-6.5 | 15 | 0.2 | 0.1-0.3 |
2001 | 437 | 6.2 | 5.6-6.8 | 19 | 0.3 | 0.2-0.4 |
2002 | 427 | 6.1 | 5.5-6.7 | 25 | 0.4 | 0.2-0.5 |
2003 | 478 | 6.9 | 6.3-7.5 | 19 | 0.3 | 0.2-0.4 |
2004 | 464 | 6.7 | 6.1-7.3 | 19 | 0.3 | 0.2-0.4 |
2005 | 489 | 7.1 | 6.5-7.8 | 14 | 0.2 | 0.1-0.3 |
2006 | 464 | 6.8 | 6.2-7.4 | 23 | 0.3 | 0.2-0.5 |
2007 | 500 | 7.3 | 6.7-8.0 | 7 | 0.1 | 0.0-0.2 |
2008 | 518 | 7.6 | 7.0-8.3 | 15 | 0.2 | 0.1-0.4 |
2009 | 506 | 7.4 | 6.8-8.1 | 15 | 0.2 | 0.1-0.4 |
2010 | 510 | 7.5 | 6.9-8.2 | 28 | 0.4 | 0.3-0.6 |
2011 | 509 | 7.4 | 6.8-8.1 | 16 | 0.2 | 0.1-0.3 |
2012 | 540 | 8.0 | 7.3-8.7 | 18 | 0.3 | 0.2-0.4 |
2013 | 478 | 7.1 | 6.4-7.8 | 13 | 0.2 | 0.1-0.3 |
2014 | 499 | 7.4 | 6.7-8.1 | 17 | 0.3 | 0.1-0.4 |
2015 | 499 | 7.3 | 6.7-8.0 | 18 | 0.2 | 0.1-0.4 |
2016 | 515 | 7.7 | 7.0-8.4 | 14 | 0.2 | 0.1-0.3 |
2017 | 503 | 7.6 | 7.0-8.3 | 14 | 0.2 | 0.1-0.3 |
2018 | 526 | 8.0 | 7.3-8.7 | 16 | 0.2 | 0.1-0.3 |
2019 | 487 | 7.4 | 6.8-8.2 | 27 | 0.4 | 0.2-0.5 |
2020 | 460 | 7.2 | 6.6-7.9 | 23 | 0.4 | 0.2-0.5 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
- Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
- The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.